Besin Denied Quick Exit In Testosterone Replacement MDL
By Kat Sieniuc ( October 11, 2016, 11:06 PM EDT) -- An Illinois federal judge overseeing multidistrict litigation over heart health risks and injuries allegedly caused by testosterone replacement therapy drugs refused Monday to toss claims against Belgian drug manufacturer Besins Healthcare, saying consumers have convincingly shown the pharmaceutical company sells enough of its product in the U.S. to remain in the litigation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.